Encompass Health Corporation (EHC) Tops Q4 EPS by 1c, Offers Guidance

Encompass Health Corporation (NYSE: EHC) reported Q4 EPS of $0.85, $0.01 better than the analyst estimate of $0.84. Revenue for the quarter came in at $1.18 billion versus the consensus estimate of $1.18 billion.

GUIDANCE:

Encompass Health Corporation sees FY2020 EPS of $3.50-$3.72, versus the consensus of $3.70. Encompass Health Corporation sees FY2020 revenue of $4.85-4.95 billion, versus the consensus of $4.88 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs
• AXT appoints Tracy Liu to its board of directors